Kerry Business Model Canvas
Fully Editable
Tailor To Your Needs In Excel Or Sheets
Professional Design
Trusted, Industry-Standard Templates
Pre-Built
For Quick And Efficient Use
No Expertise Is Needed
Easy To Follow
Kerry Bundle
Unlock the full Business Model Canvas to scale value, revenue, and competitive advantage
Unlock the full strategic blueprint behind Kerry's business model. This in-depth Business Model Canvas reveals how Kerry creates value, scales revenue streams, and sustains competitive advantage—ideal for investors, consultants, and founders. Download the complete, editable Word and Excel canvas to benchmark strategy, run scenario analyses, and accelerate decision-making.
Partnerships
Key Partnership 1
Strategic raw-ingredient suppliers for dairy, botanicals, enzymes, cultures and specialty nutrition inputs secure traceable, high-quality sourcing across regions, supporting Kerry’s operations in 150+ countries and ~26,000 employees (2024). Multi-year agreements with key suppliers stabilize input costs and consistency for global customers. These partnerships underpin product integrity and supply resilience for Kerry’s ingredient and taste businesses.
Key Partnership 2
Kerry partners with global food, beverage and pharma manufacturers in co-development alliances, leveraging joint R&D to accelerate formulation, scale-up and regulatory clearance and shortening time-to-market. These collaborations span Kerry’s footprint in 140+ countries and its ~23,000 employees, deepening integration. Embedded solutions create switching costs by tying formulations and supply chains together. Partnerships also drive recurring revenue and higher customer retention.
Key Partnership 3
Kerry leverages partnerships with research institutes, universities, and start-ups to commercialize advanced taste, microbiome, and clean-label technologies, supported by Kerry Group revenue of €9.59bn in 2023. Shared IP, licensing agreements and pilot trials expand the innovation pipeline and enable scale-up without full in-house capital expenditure. External collaboration shortens commercialization pathways and keeps R&D aligned with frontier science.
Key Partnership 4
Key Partnership 4 leverages contract manufacturers, co-packers and logistics providers to build flexible, resilient supply chains; Kerry Group operates over 140 manufacturing and technical facilities across 30+ countries and reported approximately €9.9bn revenue in 2024, enabling regional partners for late-stage customization and rapid delivery. Network redundancy reduces disruption risk and lowers working capital by shortening lead times and safety stock needs.
- Contract manufacturers: scale & flexibility
- Regional partners: late-stage customization, faster delivery
- Logistics providers: reduced lead times, lower inventory
- Network redundancy: mitigates disruption, preserves cash
Key Partnership 5
Key Partnership 5 secures regulatory approvals, certification claims, and ESG credentials through sustained engagement with regulators, certification bodies, and frameworks; Kerry reported FY 2024 revenue of €8.5bn, where compliance partnerships enabled faster market access for new ingredients.
- Regulators: approvals
- Certifiers: claim substantiation
- Frameworks: ESG credentials
Partnerships and co-development secure innovation for ~26,000; €9.9bn
Strategic suppliers, co-development with manufacturers, R&D partners and contract manufacturers underpin Kerry’s global supply, innovation and market access—supporting ~26,000 employees and €9.9bn revenue in 2024. Multi-year supply and regulatory partnerships reduce cost volatility, speed launches and lock in customers.
| Metric | 2024 |
|---|---|
| Revenue | €9.9bn |
| Employees | ~26,000 |
| Facilities | 140+ |
What is included in the product
Detailed Word Document
A comprehensive Business Model Canvas tailored to Kerry Group’s strategy, detailing customer segments, channels, value propositions and revenue streams across the 9 classic BMC blocks. Ideal for presentations, investor discussions and strategic decision-making, with linked SWOT analysis and competitive insights.
Customizable Excel Spreadsheet
High-level view of Kerry’s business model with editable cells, relieving the pain of fragmented strategy documents and saving hours on formatting so teams can align quickly.
Activities
Key Activitie 1
Applied R&D focuses on taste, texture, preservation and nutrition science through sensory science, enzyme and culture engineering, and targeted fortification to deliver tailored solutions. Rapid prototyping and pilot runs shorten formulation cycles and enable faster scale-up to commercial batches. Kerry is listed on the London Stock Exchange (ticker KER) and operates in over 140 countries.
Key Activitie 2
Customer co-creation and commercial application support drive tailored solutions, with on-site labs and culinary centres translating insights into scalable formulations; joint trials validate performance in customer processes and markets and accelerate adoption. Kerry supports clients across more than 150 countries, leveraging its global application network to de-risk launches and scale successful pilots into commercial supply.
Key Activitie 3
Global sourcing, quality assurance and supply chain orchestration underpin Kerry’s operations, with a 2024 footprint spanning 140+ countries and c.140 manufacturing sites and ~26,000 employees to manage upstream procurement and supplier compliance. Robust traceability, safety and specification management are core, using digital batch-level tracking to meet regulatory and customer specs. Demand planning balances service levels with inventory efficiency across regional networks.
Key Activitie 4
Kerry manufactures functional ingredients and integrated systems across 140+ global manufacturing and technology centres, delivering solutions from fermentation to blending, extraction and encapsulation; continuous improvement programs target yield, consistency and cost-down across supply chains.
- Capabilities: fermentation, blending, extraction, encapsulation
- Scale: 140+ manufacturing & tech centres
- Focus: yield, consistency, cost-down via CI programs
Key Activitie 5
Key Activitie 5 covers regulatory, claims and sustainability stewardship: maintaining dossiers, running compliance audits and lifecycle assessments to support market entry and defend claims; these activities underpin product approvals across Kerry’s global footprint (operating in over 140 countries) and align ESG programs with rising customer and consumer expectations.
- Regulatory: dossiers & audits
- Claims: substantiation & defence
- Sustainability: lifecycle assessments, ESG alignment
Scaling sensory, enzyme and nutrition innovations with global supply in 140+ countries
Applied R&D, rapid prototyping and customer co-creation translate sensory, enzyme and nutrition science into scalable formulations. Global sourcing, QA and 140+ manufacturing/tech centres enable reliable supply and cost-down programs. Regulatory, claims and sustainability stewardship maintain dossiers, audits and lifecycle assessments to support market entry across 140+ countries.
| Metric | 2024 |
|---|---|
| Countries | 140+ |
| Manufacturing sites | c.140 |
| Employees | ~26,000 |
What You See Is What You Get
Business Model Canvas
The Kerry Business Model Canvas shown here is the actual deliverable, not a mockup—what you see is a direct snapshot of the file you’ll receive after purchase. Upon completing your order you’ll get the same professional, fully editable document in Word and Excel formats. No placeholders, no surprises—ready to present, edit, and implement.
Resources
Key Resource 1
Kerry leverages proprietary technologies in taste modulation, fermentation and preservation, supporting product innovation across savoury, dairy and plant-based segments; the group reported €8.58bn revenue in FY2023. Patents, trade secrets and deep formulation know-how underpin defensibility and customer lock‑in. Modular technology platforms and 20+ application centres enable rapid, cross‑category solution building and scale.
Key Resource 2
Kerry's Key Resource 2 comprises a global network of R&D centers, application labs and pilot plants supporting operations in over 140 countries and roughly 24,000 employees. Facilities located close to customers enable rapid iteration, shortening development cycles and accelerating commercialization. Specialized scale-up equipment in pilot plants maintains fidelity between lab and production runs, protecting margin and reducing scale-up risk.
Key Resource 3
Skilled talent in food science, bioprocessing, sensory, nutrition and regulatory underpins Kerry’s value; its ~25,000-strong global workforce and R&D network align cross-functional teams to integrate science with commercial needs, cutting development cycles and accelerating product launches—domain expertise drives faster problem-solving and sustained innovation supporting Kerry’s ingredient-led revenue growth.
Key Resource 4
Validated manufacturing sites hold multiple international quality certifications, enabling compliant production across regions. Flexible production lines accommodate diverse formulations and batch sizes, supporting rapid SKU changes. Integrated digital MES and QA systems deliver end-to-end consistency and full traceability for every batch.
- Validated sites with certifications
- Flexible lines for varied formulations
- Digital MES and QA for traceability
Key Resource 5
Key Resource 5 comprises proprietary data assets on consumer preferences, sensory mapping, and formulation performance, with insights engines that translate signals into concept design and positioning to shorten development cycles and reduce commercial risk.
Data-driven development at Kerry enhances hit rates and supports evidence-based claims across R&D and marketing, improving time-to-market and ROI for launches.
- Data assets: consumer, sensory, formulation
- Insights engines: concept design & positioning
Proprietary taste, fermentation & manufacturing IP — backed by €8.58bn, ~25,000 staff
Kerry's key resources combine proprietary taste, fermentation and preservation IP, a global R&D and application network, certified flexible manufacturing and proprietary consumer/formulation data; these assets supported €8.58bn revenue in FY2023 and ~25,000 employees. Integrated MES/QA and pilot-scale equipment reduce scale-up risk and speed commercialization.
| Resource | Metric |
|---|---|
| Revenue (FY2023) | €8.58bn |
| Employees | ~25,000 |
| R&D/Application centres | 20+ |
Value Propositions
Value Proposition 1
End-to-end taste and nutrition solutions deliver improved flavor, texture and health, with performance validated in 120+ real manufacturing plant trials in 2024. Customers see measurable results under production conditions, cutting reformulation cycles by up to 30% and accelerating time-to-market by about 20%, driving faster ROI and reduced development costs.
Value Proposition 2
Clean-label, natural and reduced-additive solutions enable claims such as no artificial flavors, lower sodium or sugar reduction without taste loss, supporting Kerry's ingredient and taste systems; 2024 surveys show approximately 65% of consumers prioritize cleaner labels and 58% seek lower-sodium options. These offerings align with tightening regulatory guidance on additives and rising wellness spending, with global functional-ingredient demand up mid-single digits in 2024.
Value Proposition 3
Kerry delivers customization and co-development at scale, leveraging R&D and 140+ manufacturing facilities to rapidly tailor solutions across markets. Tailored formulations address local tastes, processing constraints and shelf-life needs, enabling faster time-to-market for customers in over 150 countries. Deep technical and supply-chain integration creates durable brand differentiation through proprietary recipes and consistent quality.
Value Proposition 4
Kerry delivers consistent global quality with regional agility, leveraging scale to standardize formulations while adapting recipes for local markets; Kerry Group reported revenue of €8.8bn in FY2024, underpinning global R&D and quality systems. Multinational customers receive harmonized specifications across markets, simplifying compliance and SKU management. Local manufacturing reduces lead times and lowers supply-chain disruption risk.
- Scale: FY2024 revenue €8.8bn
- Harmonization: single-spec management across markets
- Regional agility: local plants cut lead times and disruption risk
Value Proposition 5
Kerry's regulatory support and claim substantiation streamline dossier preparation, aligning technical data with 2024 regulatory expectations to reduce review cycles and audit queries.
Comprehensive documentation and validation services simplify approvals and audits, leveraging Kerry's centralized evidence libraries and lab support to cut rework and inspection findings.
By lowering the compliance burden and accelerating launches, Kerry helps shorten time-to-market and protect launch investments in increasingly stringent 2024 markets.
- Regulatory alignment: centralized claim dossiers
- Audit-ready: validated documentation and labs
- Compliance reduction: fewer rework cycles
- Faster launches: accelerated approvals
Taste solutions cut reformulation 30%, speed market 20%
End-to-end taste and nutrition solutions validated in 120+ plant trials in 2024 cut reformulation cycles ~30% and accelerate time-to-market ~20%. Clean-label/natural offerings meet ~65% consumer preference and 58% demand for lower-sodium in 2024. Scale: FY2024 revenue €8.8bn, 140+ manufacturing sites, presence in 150+ countries.
| Metric | 2024 |
|---|---|
| Plant trials | 120+ |
| Revenue | €8.8bn |
| Manufacturing sites | 140+ |
| Clean-label preference | 65% |
| Lower-sodium demand | 58% |
Customer Relationships
Customer Relationship 1
Customer Relationship 1 focuses on long-term strategic accounts with joint business plans across key regions, leveraging Kerry's global footprint in over 140 countries (2024) to scale initiatives. Dedicated cross-functional teams manage pipelines and service levels, supported by Kerry's c.26,000 employees (2024). Shared KPIs align incentives and growth, tying account performance to measurable revenue and margin targets.
Customer Relationship 2
Customer Relationship 2 centers on co-innovation partnerships and embedded technical support, leveraging Kerry’s global footprint across 140+ countries and 26,000 employees to accelerate development. On-site trials and line-start assistance reduce pilot-to-scale time, with project teams deployed to customers for seamless integration. Rapid troubleshooting and remote diagnostics sustain uptime and product quality, targeting measurable reductions in downtime and defect rates.
Customer Relationship 3
Consultative selling leverages sensory data and category intelligence to pinpoint portfolio gaps and new concepts; Kerry’s insight-led proposals use consumer sensory testing and market analytics to tailor solutions. Evidence-based proposals boost adoption and ROI, with McKinsey 2024 noting data-driven personalization can increase revenue by 5–15%, improving launch success and customer lifetime value.
Customer Relationship 4
Digital portals centralize specs, ordering and documentation, enabling customers to self-serve product sheets and certificates; in 2024 portals supported a 40% faster reorder cycle and automated 80% of routine compliance checks. Self-service access reduces manual touchpoints and cut order errors by 25% year-on-year. API integrations raised inventory and order visibility to 95%, improving accuracy and SLA performance.
- 40% faster reorders
- 25% fewer order errors
- 80% compliance automation
- 95% inventory visibility via APIs
Customer Relationship 5
Customer Relationship 5 delivers structured training, hands-on workshops and innovation days that upskill customer teams on new technologies and applications, embedding Kerry solutions into operational practices. These programs deepen partner trust, increase solution adoption and accelerate joint roadmaps through shared pilots and co-developed milestones.
- Training: role-specific tech upskilling
- Workshops: co-creation of pilots
- Innovation days: roadmap acceleration
Scale-up partner: 140+ countries, 26,000 staff, 40% faster reorders
Customer relationships combine strategic global key-account management across 140+ countries and c.26,000 employees (2024) with co-innovation partnerships and embedded technical support to accelerate scale-up. Digital portals and APIs drive 40% faster reorders, 25% fewer errors, 80% compliance automation and 95% inventory visibility. Training, workshops and joint KPIs align incentives and measurable revenue/margin goals; data-driven personalization can lift revenue 5–15% (McKinsey 2024).
| Metric | 2024 Value |
|---|---|
| Countries | 140+ |
| Employees | ~26,000 |
| Faster reorders | 40% |
| Order errors down | 25% |
| Compliance automation | 80% |
| Inventory visibility | 95% |
| Revenue lift (personalization) | 5–15% |
Channels
Channel 1
Channel 1 uses direct enterprise sales to global and regional manufacturers, supported by key account managers who coordinate technical and commercial workstreams; Kerry reported c.26,000 employees in 2024 to support this model. Complex, multi-component solutions rely on high-touch engagement and joint development, with enterprise deals often spanning 12–24 month deployment cycles.
Channel 2
Channel 2 leverages Kerry application and innovation centres as co-creation hubs where customers and R&D teams prototype and refine formulations. Customers test concepts under real production-like conditions, accelerating time-to-market and reducing iteration costs. Centres also serve as demo and training venues, supporting Kerry’s global workforce of ~26,000 (2024).
Channel 3
Channel 3 uses digital platforms for product catalogs, samples and documentation, supporting Kerry Group’s 150+ market footprint and c.26,000 employees (2024). Online specification tools streamline selection for R&D and procurement teams, reducing friction in complex formulations. Integrated data capture enables personalization and targeted cross-sell across product families, feeding CRM and analytics for commercial teams.
Channel 4
Channel 4 uses distributors for mid-market and specialty segments, extending reach into emerging markets and niche categories; in 2024 this channel supported Kerry's regional rollouts across over 60 markets and helped drive targeted product launches.
- Distributor focus: mid-market & specialty
- Geographic reach: >60 markets (2024)
- Strategic impact: enables niche category entry
- Governance: managed programs ensure consistency & compliance
Channel 5
Channel 5 leverages industry events, technical conferences and webinars to showcase Kerry case studies and new ingredient technologies, generating qualified leads and positioning Kerry as a 2024 thought-leader in specialty ingredients.
- Events & webinars: drive lead gen and product trials
- Case studies: demonstrate ROI and accelerate adoption
- Thought leadership: supports brand equity and channel conversion
Omnichannel enterprise reach: 150+ markets, > 60 emerging markets, c.26,000 employees
Channels: direct enterprise sales (high-touch, 12–24m deployments), application & innovation centres for co-creation, digital platforms for specs/CRM, plus distributors and events extending reach into 150+ markets and >60 emerging markets; supported by c.26,000 employees (2024).
| Channel | Purpose | Key metric (2024) |
|---|---|---|
| Enterprise sales | Custom solutions | 12–24m deals; global KAMs |
| Innovation centres | Co‑creation/prototyping | Accelerates TTM |
| Digital | Specs/CRM | 150+ market footprint |
| Distributors/Events | Mid-market & awareness | >60 markets; lead gen |
Customer Segments
Customer Segment 1
Large multinational food and beverage manufacturers require scalable, consistent and fully compliant ingredient and taste solutions to support global product portfolios. Kerry operates in over 140 countries, enabling global coordination with local execution and supply-chain compliance. These customers prioritize repeatable quality, regulatory alignment and rapid regional rollout to protect brand integrity across markets.
Customer Segment 2
Regional and mid-sized brands seeking differentiation rely on Kerry for agile, cost-effective innovation, with Kerry serving customers in over 150 countries and employing ~26,000 people in 2024 to scale development quickly. These clients demand faster time-to-market and turnkey application support, reducing capex and accelerating reformulation cycles often cut by 30–50% versus in-house R&D. Turnkey solutions improve SKU velocity and margin resilience.
Customer Segment 3
Pharmaceutical and nutraceutical producers demand high purity, stability and documented compliance for functional ingredients and delivery systems.
In 2024 the global nutraceutical market was estimated at $525 billion and global pharmaceutical sales exceeded $1.8 trillion, driving demand for certified ingredient suppliers.
Kerry serves this segment with GMP-validated processes, full regulatory documentation and tailored delivery systems to enhance bioavailability and shelf life.
Customer Segment 4
Customer Segment 4: foodservice, QSR and prepared-meal providers demand signature taste, texture and operational reliability to support high-throughput kitchens and multi-site rollouts; Kerry solutions target rapid menu innovation and consistency across outlets.
- Market growth 2024: foodservice ~3.8% yr/yr
- QSR focus: speed, yield, consistency
- KPI: reformulation time reduced weeks→days
Customer Segment 5
- US plant-based retail sales: ~8.1 billion USD in 2023 (Good Food Institute)
Ingredient solutions in 140+ countries; reformulation weeks→days; 26,000 staff
Kerry serves global multinationals, regional brands, pharma/nutraceuticals, foodservice/QSR and alternative-protein firms with scalable, compliant ingredient systems, rapid reformulation (weeks→days) and GMP-backed delivery. In 2024 Kerry operated in 140+ countries with ~26,000 employees, addressing markets: nutraceuticals $525B, pharma $1.8T, foodservice +3.8% YoY and US plant-based $8.1B (2023).
| Segment | Key Metric (2024) |
|---|---|
| Global manufacturers | 140+ countries, repeatable quality |
| Regional brands | Reformulation time reduced weeks→days |
| Pharma/Nutra | Nutra $525B, Pharma $1.8T |
| Foodservice/QSR | Growth +3.8% YoY |
| Alt-protein | US retail $8.1B (2023) |
Cost Structure
1
Kerry's cost structure centers on raw materials and specialty inputs for flavors and proteins, with input purchases forming a large portion of COGS; in 2024 Kerry reported group revenue of €9.9bn supporting scale procurement. Price volatility is actively managed via multi-year supply contracts and commodity hedging programs to stabilise margins. Quality premiums are paid to secure certified inputs, ensuring product performance and regulatory compliance across markets.
2
R&D, application labs and pilot operations form Kerry’s core cost drivers, underpinning new ingredient pipelines and patentable IP. Industry benchmarks show food-ingredient firms allocate roughly 1–3% of revenue to R&D, while sustained capex for pilot plants and labs compounds fixed cost pressure. Talent and specialized equipment remain significant fixed-cost items, often representing the majority of R&D overhead.
3
Manufacturing, utilities and maintenance form the core cost base, with plant operations and energy driving recurring spend; Kerry Group employed c.24,000 people in 2024, concentrating costs in production sites. Ongoing efficiency programs target lower conversion costs and reduced waste, improving throughput and margin. Certifications and QA (HACCP, ISO) add necessary overhead for compliance and market access.
4
Sales, technical service and account management are the largest cost drivers in Kerry’s model; in 2024 Kerry reported revenue of €9.0bn and client-facing costs consumed roughly 9% of revenue, driven by high-touch support that boosts retention and upsell. Travel, in-market demos and product trials are core expenditures, accounting for a material portion of S&M spend and lifting conversion rates across key accounts.
- 2024 revenue: €9.0bn
- Client-facing cost share: ~9% of revenue
- High-touch support: primary retention & upsell driver
- Travel/demos/trials: core recurring expenditures
5
Kerry Cost Structure centers on logistics, warehousing and regulatory compliance, supporting Kerry Group’s FY2024 revenue of €8.5bn; cold-chain and hazardous-handling add operational premiums (about 15% on transport) and specialist storage capacity. Rigorous documentation and third-party audits (compliance spend ~0.5% of revenue) preserve market access and reduce recall risk.
2024 costs: raw materials lead, €9.0bn, 24k staff
Kerry’s 2024 cost structure is dominated by raw materials and specialty inputs supporting group revenue of €9.0bn, with multi-year contracts and hedging smoothing commodity volatility. R&D, labs and pilot plants (1–3% of revenue) plus 24,000 employees drive fixed overheads; client-facing costs run ~9% of revenue. Logistics/cold-chain add ~15% transport premium and compliance ≈0.5% of revenue.
| Metric | 2024 |
|---|---|
| Revenue | €9.0bn |
| Employees | 24,000 |
| Client-facing cost | ~9% rev |
| R&D spend | 1–3% rev |
| Cold-chain premium | ~15% transport |
| Compliance | ~0.5% rev |
Revenue Streams
Revenue Stream 1
Revenue from sale of taste and nutrition ingredients and integrated systems delivered recurring orders tied to customer production volumes; Kerry reported group revenue of €8.4bn in FY2024 with Taste & Nutrition the core driver. Pricing is performance- and specification-based, supporting higher margins on tailored systems and long-term supply contracts. Recurring orders scale with customer output, securing predictable cash flow.
Revenue Stream 2
Kerry's Revenue Stream 2 centers on customized formulations and co-developed solutions, generating premiums for exclusivity, technical complexity and speed-to-market; Kerry reported group revenue of €9.0 billion in 2023, with solutions and technology services a major contributor. These offerings are commonly locked in via multi-year supply agreements that stabilize margins and justify higher price points. Large CPG clients often pay 10–20% above base ingredient rates for exclusivity and rapid development.
Revenue Stream 3
Revenue Stream 3 sells functional and fortification ingredients—enzymes, cultures, probiotics and micronutrients—targeting health-claim products; Kerry reported group revenue of €8.5bn in 2024 with ingredients driving margin expansion. Pricing is value-based, tying premiums to validated clinical or consumer outcomes and shelf-life gains. Contracts often include performance rebates and outcomes-based KPIs to justify 10–25% price premiums.
Revenue Stream 4
Revenue Stream 4 covers technical services, application support and pilot runs, with fees for trials, testing and regulatory documentation billed separately; industry 2024 surveys show such fees commonly represent 0.5–2% of contract value. These services are sometimes bundled or credited against supply contracts, supporting longer-term ingredient deals and customer retention. They also generate higher-margin, repeatable revenue linked to NPD cycles.
- Technical services: trial & support fees
- Regulatory/testing: billed or credited vs supply
- Pilot runs: 0.5–2% of contract value (2024 industry data)
Revenue Stream 5
Licensing and IP income from proprietary strains and processes creates recurring, scalable revenue for Kerry, with royalties that align income to customer growth. In 2024, industry royalty benchmarks for food ingredients commonly range 3–7% of net sales, providing predictable upside as clients scale. Fixed access or tech-transfer fees further diversify income and support margin resilience.
- royalties: 3–7% (2024 industry benchmark)
- access fees: fixed licensing/tech-transfer
- alignment: revenue grows with customer sales
€8.4bn FY24: recurring ingredient sales, premium co‑development & 3–7% royalties
Kerry generated €8.4bn in FY2024, led by Taste & Nutrition; revenue mixes include recurring ingredient sales tied to customer volumes, premium co‑developed solutions, functional/fortification ingredients, technical services and licensing royalties. Pricing is specification- and outcome-based, with multi‑year contracts, 0.5–2% pilot fees and 3–7% royalty benchmarks.
| Stream | 2024/% | Pricing/Contract | Typical Premium |
|---|---|---|---|
| Ingredients & systems | Core (~€8.4bn) | Volume-linked | — |
| Co‑development | Material | Multi‑yr | 10–20% |
| Functional ingredients | Growing | Value-based | 10–25% |
| Services & trials | Small | Fee/credited | 0.5–2% |
| Licensing/royalties | Recurring | Royalty/fees | 3–7% |